CIC Wealth’s Pfizer PFE Stock Holding History

CIC Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,845	Closed	-$581K	–	161
2023 Q2	$581K	Sell	15,845 -5,842	-27%	-$227K	0.2%	87
2023 Q1	$885K	Buy	21,687 +35	+0.2%	+$1.51K	0.33%	62
2022 Q4	$1.11M	Buy	+21,652	New	+$1.04M	0.46%	57

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CIC Wealth's PFE Position: Q3 2023 in Review

CIC Wealth sold out of Pfizer (PFE) in Q3 2023, closing a stake of 15,845 shares — an estimated $581K sold.

CIC Wealth first reported a position in PFE in Q4 2022 and held it in 3 quarters. The position peaked at $1.11M in Q4 2022. 2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

CIC Wealth reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
CIC Wealth sold 15,845 Pfizer shares in Q3 2023, an estimated $581K.
CIC Wealth first reported a position in Pfizer in Q4 2022 and held it in 3 quarters.
CIC Wealth's Pfizer position peaked at $1.11M in Q4 2022.
2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on CIC Wealth's 13F filing for Q3 2023, filed 10 Oct 2023.